Min Shi

626 citations
24 papers · 473 indexed · h-index 11
Topics
Hormonal Regulation and Hypertension (3 papers)Renal cell carcinoma treatment (2 papers)Cardiovascular Function and Risk Factors (2 papers)

In The Last Decade

Min Shi

22 papers receiving 467 citations

Peers

Min Shi
Comparison fields: 5 of 81
  • Endocrinology, Diabetes and Metabolism 137
  • Molecular Biology 126
  • Pulmonary and Respiratory Medicine 103
  • Immunology 90
  • Cardiology and Cardiovascular Medicine 62
Replace Anna‐Lena Eriksson with:
Anna‐Lena Eriksson Sweden
Stefanie Ruhs Germany
Talat Afroze Canada
F Russo-Marie France
Vincent Healy Ireland
Constantin Bode Germany
Darijana Horvat United States
Éva Dizin Switzerland
Christine Shugrue United States
Toshiharu Onodera Japan
Min Shi relative to Anna‐Lena Eriksson Sweden Anna‐Lena Eriksson's profile →
Citations per field
00.5×9.2×
Anna‐Lena Eriksson · 1×
Citations per year

Countries citing papers authored by Min Shi

Since Specialization
Citations

This map shows the geographic impact of Min Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Shi more than expected).

Fields of papers citing papers by Min Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Shi. The network helps show where Min Shi may publish in the future.

Co-authorship network of co-authors of Min Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Min Shi. A scholar is included among the top collaborators of Min Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Shi. Min Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 4
5 4
6 1
7 0
8 2
9 8
10 8
11 16
12 14
13 20
14 10
15 42
16 49
17 101
18 26
19 54
20 86

About Min Shi

Min Shi is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Complementary and alternative medicine, having authored 24 papers that have together received 473 indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (3 papers), Renal cell carcinoma treatment (2 papers) and Cardiovascular Function and Risk Factors (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (137 citations), Immunology (90 citations) and Pulmonary and Respiratory Medicine (103 citations). Min Shi has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Tsung H. Lin, Kenneth C. Appell, Leslie J. Berg, Darren M. Roesch, Wei Zheng, Joseph G. Verbalis, Kathryn Sandberg, Бо Лi, Ying Tian and Qian Li. Their work appears in journals such as Immunity, Scientific Reports and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026